Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells

Cell Biology International

Volumn 23, Issue 8, 1999, Pages 541-550

  Tanaka, Tetsuya ^a   Satoh, Takatomo ^b   Onozawa, Yoshiko ^a   Kohroki, Junya ^a   Itoh, Norio ^a   Ishidate Jr , Motoi ^b   Muto, Norio ^a,c   Tanaka, Keiichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OLYMPUS CORPORATION   (Japan)

^c PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

Apoptosis; Butyrate; Differentiation; Embryonal carcinoma; Iron chelator; Retinoic acid

Indexed keywords

BUTYRIC ACID; DEFEROXAMINE; DITHIZONE; DNA; RETINOIC ACID; THUJAPLICIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; DNA DEGRADATION; DRUG ACTIVATION; DRUG INHIBITION; EMBRYONAL CARCINOMA; IRON CHELATION; NONHUMAN; TUMOR DIFFERENTIATION;

EID: 0033493243     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1999.0407     Document Type: Article

References (35)

1. Atencia R, Garcia-Sanz M, Unda F, Arechaga J. Apoptosis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp Cell Res. 214:1994;663-667.
2. Bergeon RJ, Ingeno MJ. Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy. Cancer Res. 47:1987;6010-6016.
3. Burton K. Determination of DNA concentration with diphenylamine. Methods Enzymol. 12:1968;163-166.
4. Clifford J, Chiba H, Sobieszczuk D, Metzger D, Chambon P. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J. 15:1996;4142-4155.
5. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270:1977;347-349.
6. Eastman A. Assays for DNA fragmentation, endonucleases, and intracellular pH and Ca2+ associated with apoptosis. Methods Cell Biol. 46:1995;41-55.
7. Evans G, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr Biol. 7:1995;825-834.
8. Fontecave M, Nordloud P, Eklund H, Richard P. The redox centers of ribonucleotide reductase of Escherichia coli. Adv Enzymol. 65:1992;148-183.
9. Gallagher RE, Collins SJ, Trujilli J, McCredie K, Ahearn M, Tsai S, Metzgaer R, Aulakh G, Ting R, Ruscetti F, Gallo R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelicytic leukemia. Blood. 54:1979;713-733.
10. Glozak MA, Rogers MB. Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4. Dev Biol. 179:1996;458-470.
11. Hogan BLM, Barlow DP, Tilly R. F9 teratocarcinoma cells as a model for the differentiation of parietal and visceral endoderm in the mouse embryo. Cancer Surv. 2:1983;116-140.
12. Horn V, Minucci S, Ogrtzko VV, Adamson ED, Howard BH, Levin AA, Ozato L. RAR and RAX selective ligands cooperatively induce apoptosis and neural differentiation in P19 embryonal carcinoma cells. FASEB J. 10:1966;1071-1077.
13. Illera VA, Perandones CE, Stunz LL, Mower DA Jr, Ashman RF. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol. 151:1993;2965-2973.
14. Inamori Y, Tsujibo H, Ohishi H, Ishii F, Misugaki M, Aso H, Ishida N. Cytotoxic effect of hinokitiol and tropolone on the growth of mammalian cells and on blastogenesis of mouse splenic T cells. Biol Pharm Bull. 16:1992;521-523.
15. Kudoh T, Ishidate T, Nakamura T, Toyoshima K, Akiyama T. Constitutive expression of the Wilms tumor suppressor gene WT1 in F9 embryonal carcinoma cells induces apoptotic cell death in response to retinoic acid. Oncogene. 13:1996;1431-1439.
16. Langley RE, Palayoor ST, Coleman CN, Bump EA. Radiation-induced apoptosis in F9 teratocarcinoma cells. Int J Radiat Biol. 65:1994;605-610.
17. Lederman HM, Cohen A, Leww JWW, Freeman MH, Gelfand EW. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood. 64:1984;748-753.
18. Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol. 79:1990;448-453.
19. Mesner PW, Winters TR, Green SH. Nerve growth factor withdrawal-induced cell death in neronal PC12 cells resembles that in sympathetic neurons. J Cell Biol. 119:1992;1669-1680.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:1983;55-63.
21. Muto N, Dota A, Tanaka T, Itoh N, Okabe M, Inada A, Nakanishi T, Tanala K. Hinokitiol induces differentiation of teratocarcinoma F9 cells. Biol Pharm Bull. 18:1995;1576-1579.
22. Ninomiya Y, Adams R, Morris-Kay GM, Eto K. Apoptotic cell death in neuronal differentiation of P19 EC cells: cell death follows reentry into S phase. J Cell Physiol. 172:1997;25-35.
23. Nishimune Y, Kume A, Ogiso Y, Matsushiro A. Induction of teratocarcinoma cell differentiation. Exp Cell Res. 146:1983;439-444.
24. Okazawa H, Shimizu J, Kamei M, Imafuku I, Hamada H, Kanazawa I. Bcl-2 inhibits retinoic acid-induced apoptosis during the neural differentiation of embryonal stem cells. J Cell Biol. 132:1996;955-968.
25. Renton FJ, Jeitner TM. Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators. Biochem Pharmacol. 51:1996;1553-1561.
26. Rubin LL, Philpott KL, Brooks SF. The cell cycle and cell death. Curr Biol. 3:1993;391-394.
27. Sellins KS, Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol. 139:1987;3319-3206.
28. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 15:1978;303-403.
29. Taimi M, Breitman TR. Growth, differentiation, and death of retinoic acid-treated human acute promyelocytic leukemia NB4 cells. Exp Cell Res. 230:1997;69-75.
30. Tanaka T, Muto N, Ido Y, Itoh N, Tanaka K. Induction of embryonal carcinoma cell differentiation by deferoxamine, a potent therapeutic iron chelator. Biochim Biophys Acta. 1357:1997;91-97.
31. Tanaka T, Muto N, Itoh N, Dota A, Nishina Y, Inada A, Tanaka K. Induction of differentiation of embryonal carcinoma F9 cells by iron chelators. Res Commun Mol Pathol Pharmacol. 90:1995;211-220.
32. Terui Y, Furukawa Y, Sakoe K, Ohta M, Saito M. Expression of differentiation-related phenotypes and apoptosis are independently regulated during myeloid cell differentiation. J Biochem. 117:1995;77-84.
33. Tomoyasu S, Fukuchi K, Yajima K, Watanabe K, Suzuki H, Kawakami K, Gomi K, Tsuruoka W. Suppression of HL-60 cell proliferation by deferoxamine: changes in c -myc expression. Anticancer Res. 13:1993;407-410.
34. Wan YJ, Wang L, Wu TC. Different response to retinoic acid of two teratocarcinoma cell lines. Exp Cell Res. 219:1995;392-398.
35. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis in associated with endogenous endonuclease activation. Nature. 284:1980;555-556.